Astellas Pharma (JP:4503) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Astellas Pharma Inc. has announced the successful pricing of its 5th and 6th series JPY denominated unsecured bonds, aimed at repaying and redeeming short-term fundings. The bonds total JPY 100 billion, with the 5th series bond at JPY 80 billion with a 0.870% interest rate and a 5-year maturity, and the 6th series bond at JPY 20 billion with a 1.038% interest rate and a 7-year maturity. Both series are set to be publicly offered with no collateral guarantees but include a negative pledge clause, with Mizuho Securities and others as lead managers.
For further insights into JP:4503 stock, check out TipRanks’ Stock Analysis page.
